The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 1-2, 2011, Pages 5-10

  Karathanasis, Nikolaos V ^a   Stiakaki, Eftichia ^a   Goulielmos, George N ^b   Kalmanti, Maria ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; STOMATITIS; THROMBOCYTE COUNT;

CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 79951994081     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0083     Document Type: Article

References (22)

1. Aplenc R, Thompson J, Han P, et al. (2005) Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 65:2482-2487. (Pubitemid 40490161)
2. Chatzidakis K, Goulas A, Athanassiadou-Piperopoulou F, et al. (2006) Methylenetetrahydrofolate reductase C677T polymorphism: Association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in Greek patients. Pediatr Blood Cancer 47:147-151. (Pubitemid 44025246)
3. Common Terminology Criteria for Adverse Events v4.0 (CTCAE) (2009) U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute. Available at http://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed June 1, 2009.
4. Dedoussis GV, Panagiotakos DB, Chrysohoou C, et al. (2004) Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C3T mutation on homocysteine concentrations in healthy adults: the ATTICA Study. Am J Clin Nutr 80:849-854. (Pubitemid 41202081)
5. De Jonge R, Hooijberg JH, van Zelst BD, et al. (2005) Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukaemia. Blood 106:717-720. (Pubitemid 40981271)
6. Frosst P, Blom HJ, Milos R, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
7. Gialeraki A, Politou M, Rallidis L, et al. (2008) Prevalence of prothrombotic polymorphisms in Greece. Genet Test 12:541-547.
8. Kantar M, Kosova B, Cetingul N, et al. (2009) Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma 50:912-917.
9. Karathanasis NV, Choumerianou DM, Kalmanti M (2009) Gene polymorphisms in childhood ALL. Pediatr Blood Cancer 52:318-323.
10. Krajinovic M, Lamothe S, Labuda D, et al. (2004) Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukaemia. Blood 103:252-257. (Pubitemid 38029946)
11. Krajinovic M, Lemieux-Blanchard E, Chiasson S, et al. (2004) Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 4:66-72. (Pubitemid 38256607)
12. Lambropoulos AF, Agorastos T, Foka ZJ, et al. (2003) Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett 191: 187-191. (Pubitemid 36255604)
13. Oliveira E, Alves S, Quental S, et al. (2005) The MTHFR C677T and A1298C Polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 27:425-429. (Pubitemid 41233298)
14. Ongaro A, De Mattei M, Della Porta MG, et al. (2009) Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. Haematologica 94:1391-1398.
15. Pereira TV, Rudnicki M, Pereira AC, et al. (2006) 5,10- Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1956-1963. (Pubitemid 44664274)
16. Pui CH, Evans WE (2006) Drug therapy-treatment of acute lymphoblastic leukemia. N Engl J Med 354:166-178.
17. Schnakenberg E, Mehles A, Cario G, et al. (2005) Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Medical Genetics 6:23.
18. Shimasaki N, Mori T, Samejima H, et al. (2006) Effects of Methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 28:64-68.
19. Stiakaki E, Germanakis I, Sfyridaki C, et al. (2005) Prevalence of factor V Leiden and other thrombophilic traits among Cretan children with malignancy. Pediatr Blood Cancer 44:386-389. (Pubitemid 40316032)
20. Taub JW, Matherly LH, Ravindranath Y, et al. (2002) Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia. Leukemia 16:764-765. (Pubitemid 34449766)
21. Wiemels JL, Smith RN, Taylor GM, et al. (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukaemia.. Proc Natl Acad Sci USA 98:4004-4009. (Pubitemid 32249888)
22. Zintzaras E, Koufakis T, Ziakas, et al. (2006) A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 21:501-510. (Pubitemid 44578327)